Complement Factor D, a serine protease of the S1 family and key component of the alternative pathway amplification loop, represents a promising target for the treatment of several prevalent and rare diseases linked to the innate immune system. Previously reported FD inhibitors have been shown to bind to the FD active site in its self-inhibited conformation characterized by the presence of a salt bridge at the bottom of the S1 pocket between Asp189 and Arg218. We report herein a new set of small-molecule FD ligands that harbor a basic S1 binding moiety directly binding to the carboxylate of Asp189, thereby displacing the Asp189-Arg218 ionic interaction and significantly changing the conformation of the self-inhibitory loop.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949727PMC
http://dx.doi.org/10.1021/acsmedchemlett.8b00104DOI Listing

Publication Analysis

Top Keywords

complement factor
8
discovery design
4
design benzylamine-based
4
benzylamine-based ligands
4
ligands binding
4
binding unlocked
4
unlocked conformation
4
conformation complement
4
factor complement
4
factor serine
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!